Vessel size index measurements in a rat model of glioma: Comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches

NMR in Biomedicine

Volumn 25, Issue 2, 2012, Pages 218-226

  Pannetier, Nicolas ^a,b   Lemasson, Benjamin ^a,b,c   Christen, Thomas ^a,b   Tachrount, Mohamed ^a,b   Troprès, Irène ^b,d   Farion, Régine ^a,b   Segebarth, Christoph ^a,b   Rémy, Chantal ^a,b   Barbier, Emmanuel L ^a,b  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b UNIV GRENOBLE ALPES   (France)

^c Unité IRM 3T ^*

^d IFR1   (France)

Author keywords

DSC; Gd; Glioma; MRI; Spiral; USPIO; Vessel size index; VSI

Indexed keywords

DSC; GLIOMA; SPIRAL; USPIO; VESSEL SIZE; VSI;

BRAIN; CHELATION; ESTIMATION; HISTOLOGY; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; TUMORS;

GADOLINIUM;

GADOTERATE MEGLUMINE; IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL DIAMETER; BRAIN TISSUE; CONTROLLED STUDY; GLIOMA; MALE; NONHUMAN; OUTCOME ASSESSMENT; PLASMA HALF LIFE; PRIORITY JOURNAL; RAT; STEADY STATE; SUSCEPTIBILITY WEIGHTED IMAGING; TISSUE PERFUSION; TUMOR VOLUME;

ANIMALS; BLOOD VESSELS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; DEXTRANS; DIFFUSION; DISEASE MODELS, ANIMAL; GADOLINIUM; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; NEOPLASM TRANSPLANTATION; ORGAN SIZE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84856022076     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1734     Document Type: Article

References (32)

1. Paulson ES, Schmainda KM. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumours. Radiology. 2008; 249: 601-613.
2. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 1990; 14: 249-265.
3. Østergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn. Reson. Med. 1996; 36: 726-736.
4. Barbier EL, Lamalle L, Décorps M. Methodology of brain perfusion imaging. J. Magn. Reson. Imaging. 2001; 13: 496-520.
5. Batchelor TT, Sorensen AG, Tomaso ED, Zhang W, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen P, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumour vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007; 11: 83-95.
6. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn. Reson. Med. 1996; 36: 715-725.
7. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumour grade, whereas uncorrected maps do not. AJNR Am. J. Neuroradiol. 2006; 27: 859-867.
8. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J. Magn. Reson. Imaging. 1997; 7: 102-110.
9. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, Ishii Y, Kubota T. Tumour vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology. 1993; 189: 233-238.
10. Barbier EL, den Boer JA, Peters AR, Rozeboom AR, Sau J, Bonmartin A. A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images. J. Magn. Reson. Imaging. 1999; 10: 242-253.
11. Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, Prost RW. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumour patients. Magn. Reson. Med. 2000; 43: 845-853.
12. Schmainda KM, Rand SD, Joseph AM, Lund R, Ward BD, Pathak AP, Ulmer JL, Baddrudoja MA, Krouwer HGJ. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumour grade and angiogenesis. AJNR Am. J. Neuroradiol. 2004; 25: 1524-1532.
13. Troprès I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Décorps M. Vessel size imaging. Magn. Reson. Med. 2001; 45: 397-408.
14. Kiselev VG, Strecker R, Ziyeh S, Speck O, Henni J. Vessel size imaging in humans. Magn. Reson. Med. 2005; 53: 553-563.
15. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumour angiogenesis. Magn. Reson. Med. 1998; 40: 793-799.
16. Jensen JH, Chandra R. MR imaging of microvasculature. Magn. Reson. Med. 2000; 44: 224-230.
17. Jensen JH, Lu H, Inglese M. Microvessel density estimation in the human brain by means of dynamic contrast-enhanced echo-planar imaging. Magn. Reson. Med. 2006; 56: 1145-1150.
18. Valable S, Lemasson B, Farion R, Beaumont M, Segebarth C, Rémy C, Barbier EL. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed. 2008; 21: 1043-1056.
19. Lemasson B, Christen T, Tizon X, Farion R, Fondraz N, Provent P, Segebarth C, Barbier EL, Genne P, Duchamp O, Rémy C. Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and antiangiogenic drug effects. NMR In Biomed. 2011; 24: 473-482.
20. Troprès I, Lamalle L, Péoc'h M, Farion R, Usson Y, Décorps M, Rémy C. In vivo assessment of tumoural angiogenesis. Magn. Reson. Med. 2004; 51: 533-541.
21. Beaumont M, Lemasson B, Farion R, Segebarth C, Rémy C, Barbier EL. Characterization of tumour angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. J. Cereb. Blood Flow Metab. 2009; 29: 1714-1726.
22. Troprès I, Lamalle L, Farion R, Segebarth C, Rémy C. Vessel size imaging using low intravascular contrast agent concentrations. MAGMA 2004; 17: 313-316.
23. Farrar CT, Kamoun WS, Ley CD, Kim YR, Kwon SJ, Dai G, Rosen BR, di Tomaso E, Jain RK, Sorensen AG. In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumour model. Neuro-oncology. 2010; 12: 341-350.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
25. Pathak AP, Ward BD, Schmainda KM. A novel technique for modeling susceptibility-based contrast mechanisms for arbitrary microvascular geometries: the finite perturber method. Neuroimage. 2008; 40: 1130-1143.
26. Barbier EL, Valable S, Lucatelli C, Troprès I, Segebarth C, Rémy C. Error Propagation in Vessel Size Index Imaging. Proceedings of the 14th Annual Meeting of ISMRM, Seattle, USA, 2006; 85.
27. Kettunen MI, Sierra A, Närväinen MJ, Valonen PK, Ylä-Herttuala S, Kauppinen RA, Gröhn OHJ. Low spin-lock field T1 relaxation in the rotating frame as a sensitive MR imaging marker for gene therapy treatment response in rat glioma. Radiology. 2007; 243: 796-803.
28. Barbier EL, St Lawrence K, Grillon E, Koretsky AP, Décorps M. A model of blood-brain barrier permeability to water: accounting for blood inflow and longitudinal relaxation effects. Magn. Reson. Med. 2002; 47: 1100-1109.
29. Bauer WR, Schulten K. Theory of contrast agents in magnetic resonance imaging: coupling of spin relaxation and transport. Magn. Reson. Med. 1992; 26: 16-39.
30. Hazlewood CF, Chang DC, Nichols BL, Woessner DE. Nuclear magnetic resonance transverse relaxation times of water protons in skeletal muscle. Biophys. J. 1974; 14: 583-606.
31. McLaughlin AC, Leigh JS. Relaxation times in systems with chemical exchange: Approximate solutions for the nondilute case. J. Magn. Reson. 1969: 1973; 9: 296-304.
32. Wendland MF, Saeed M, Yu KK, Roberts TP, Lauerma K, Derugin N, Varadarajan J, Watson AD, Higgins CB. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn. Reson. Med. 1994; 32: 319-329.